| |
| |
|
| Insider
Information: |
Brannelly Paul |
| Relationship: |
Executive Vice Preside... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
281,564 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,052,841 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
281,564 |
|
|
| Total
Value |
$7,052,841 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Karyopharm Therapeutics Inc. |
KPTI |
SVP, FINANCE & ADMIN, ... |
2014-05-15 |
66,136 |
|
0 |
Premium* |
|
|
Collegium Pharmaceutical, Inc |
COLL |
Executive Vice Preside... |
2021-02-10 |
215,428 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
39 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2016-05-18 |
4 |
A |
$16.00 |
$14,400 |
D/D |
900 |
81,276 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2016-05-20 |
4 |
A |
$16.89 |
$18,579 |
D/D |
1,100 |
82,376 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2018-08-23 |
4 |
D |
$18.03 |
$10,800 |
D/D |
(599) |
123,195 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2020-08-10 |
4 |
D |
$18.89 |
$28,618 |
D/D |
(1,515) |
173,758 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2018-08-03 |
4 |
D |
$20.15 |
$3,647 |
D/D |
(181) |
123,794 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2020-01-21 |
4 |
D |
$21.56 |
$4,614 |
D/D |
(214) |
151,173 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2020-02-10 |
4 |
D |
$21.62 |
$87,021 |
D/D |
(4,025) |
175,273 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2018-02-26 |
4 |
D |
$21.77 |
$26,059 |
D/D |
(1,197) |
133,436 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2018-02-05 |
4 |
D |
$23.38 |
$5,003 |
D/D |
(214) |
134,633 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, FINANCE & ADMIN, TREAS |
• – – |
2014-05-15 |
4 |
B |
$25.95 |
$18,165 |
D/D |
700 |
66,136 |
2.74 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2021-02-10 |
4 |
D |
$25.95 |
$220,341 |
D/D |
(8,491) |
215,428 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, FINANCE & ADMIN, TREAS |
• – – |
2014-05-14 |
4 |
B |
$26.93 |
$21,544 |
D/D |
800 |
65,436 |
2.74 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Executive Vice President & CFO |
• – – |
2018-06-21 |
4 |
AS |
$27.50 |
$279,165 |
D/D |
(10,000) |
123,436 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, FINANCE & ADMIN, TREAS |
• – – |
2014-05-13 |
4 |
B |
$28.06 |
$28,057 |
D/D |
1,000 |
64,636 |
2.74 |
- |
|
39 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
